A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Meclofenamate Patient, Information, Instructions - Meclofenamate
Meclofenamate Patient, Information, Instructions - Meclofenamate
PATIENT INFORMATION
Patients should be advised that nausea,
vomiting, diarrhea,
and abdominal pain have been associated with the use of meclofenamate
sodium. The patient should be made aware of a possible drug
connection and accordingly should consider discontinuing the drug
and contacting his or her physician
if any of these conditions are severe.
Women who are taking meclofenamate sodium
for heavy menstrual flow
should be advised to consult their doctor
if they have spotting
or bleeding between
cycles or worsening of their menstrual blood
flow. These symptoms may be signs of the development
of a more serious condition
that is not appropriately treated with meclofenamate sodium.
Meclofenamate sodium
may be taken with meals or milk
to control gastrointestinal
complaints. Concomitant administration
of an antacid (specifically,
aluminum and magnesium
hydroxides) does not interfere with the absorption
of the drug.
Meclofenamate sodium,
like other drugs of its class, is not free of side effects. The
side effects of these drugs
can cause discomfort,
and rarely, there are more serious side
effects, such as gastrointestinal
bleeding, which may result in hospitalization
and even fatal outcomes.
NSAIDs (nonsteroidal anti-inflammatory
drugs) are often essential
agents in the management of arthritis
and have a major role in
the treatment of pain,
but they also may be commonly employed for conditions which are
less serious.
Physicians may w.s. to
discuss with their patients the potential
risks (see WARNINGS, PRECAUTIONS,
and ADVERSE REACTIONS sections)
and likely benefits of NSAID
treatment, particularly
when the drugs are used for less serious conditions where treatment
without N.A.D. may represent
an acceptable alternative to both the patient
and physician.
top
